Genome Medicine·Mar 30Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonistsCohort study of 1,119 peopleGLP-1 receptor agonistsPaper
Journal of Clinical Medicine·Mar 28Impact of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) on Increased Residual Gastric Content in Patients With and Without Concurrent Colonoscopy: A Retrospective Case-Control StudyCase-control study of 3,746 peopleGLP-1 receptor agonistsPaper
PLOS One·Mar 27Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysisStudy in peopleTirzepatidePaper
Ophthalmic Surgery, Lasers & Imaging Retina·Mar 27GLP-1 Receptor Agonists: Clinical Considerations and Risk Management for Patients Undergoing Ophthalmic SurgeryReviewGLP-1 receptor agonistsPaper
bioRxiv·Mar 27Anticipatory metabolic reprogramming distinguishes caloric restriction from fasting-refeeding cyclesPreprint: experiments in miceDietary restrictionPaper
Diabetes, Metabolic Syndrome and Obesity·Mar 26Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese PopulationsReviewGLP-1 receptor agonistsPaper
Frontiers in Medicine·Mar 20Does age delay gastric emptying? Ultrasound reveals altered dynamics in the aged populationCohort study of 60 peopleMechanismsPaper
Revue Medicale Suisse·Mar 19GLP-1 agonists : indications and pancreatic and endoscopic safety considerationsReviewGLP-1 receptor agonistsPaper
Metabolism·Mar 19Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectivesReviewObesityPaper
Cureus·Mar 13The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative ReviewReviewGLP-1 receptor agonistsPaper
Diabetes, Obesity & Metabolism·Mar 10Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover StudyRandomized trial in 24 peopleObesityPaper
Journal of the American Pharmacists Association·Mar 8Semaglutide use in a patient with a long-term ileostomy: A case report highlighting clinical risks and evidence gapsCase reportSemaglutidePaper
Fizikalna I Rehabilitacijska Medicina·Mar 5THE IMPORTANCE OF PROPER NUTRITION IN PROTECTING THE MUSCULOSKELETAL SYSTEM DURING WEIGHT LOSSNon-randomized trial in 3 peopleInterventionsPaper
The Oncologist·Mar 4The emerging implications of GLP-1 receptor agonists in radiation therapyReviewGLP-1 receptor agonistsPaper
Frontiers in Endocrinology·Mar 2A pilot study on a combined non-invasive screening test for metabolic dysfunction-associated steatotic liver disease and type 2 diabetesStudy of 26 peopleMetabolic dysfunction-associated steatotic liver diseasePaper
International Immunopharmacology·Feb 22Exenatide through PPARδ improved hepatic insulin resistance in patients of type 2 diabetes mellitus via suppressing pyroptosisCohort study in peopleExenatidePaper
Perioperative Medicine·Feb 22Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risksSystematic reviewGLP-1 receptor agonistsPaper
The Journal of Clinical Investigation·Feb 16The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medicationsReviewGLP-1 receptor agonistsPaper
Current Nutrition Reports·Feb 16Psyllium Husk: A Comprehensive Review of its Functional Properties, Health Benefits, Mechanisms of Action, and Potential Adverse EffectsReviewInterventionsPaper
Diabetes Research and Clinical Practice·Feb 16The impact of GLP-1 and incretin-based therapies on counterregulatory responses to hypoglycemia in diabetes mellitus: mechanisms and clinical implicationsReviewIncretin-based therapiesPaper
Journal of Education Health and Sport·Feb 15Semaglutide-Induced Weight Loss: Consequences for Muscle Mass and Functional OutcomesReviewSemaglutidePaper
Frontiers in Endocrinology·Feb 13Anatomical evidence links the stomach to the central amygdala, a region responsive to local GLP-1R agonist induced feeding and nausea-like behaviors in male miceExperiments in miceGLP-1 receptor agonistsPaper
Obesity Surgery·Feb 13Extended Versus Standard Pouch in Roux-en-Y Gastric Bypass: Five To Nine Year Follow-Up Results of a Randomized Controlled TrialRandomized trial in 62 peopleInterventionsPaper
Metabolism·Feb 12The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potentialReviewMetabolic diseasePaper
Journal of Diabetes Science and Technology·Feb 9Modifiable Factors Affecting the Postprandial Glycemic ResponseReviewInterventionsPaper
Frontiers in Endocrinology·Feb 6Potential application of mono-, dual-, and triple-target GLP-1 receptor agonists in improving the prognosis of patients with diabetic foot ulcersReviewGLP-1 receptor agonistsPaper
Anaesthesia·Feb 3Gastric ultrasound in patients receiving semaglutide: a prospective, multicentre, matched control studyCase-control study of 44 peopleSemaglutidePaper
Molecules·Jan 28Fermented Plant-Based Foods and Postbiotics for Glycemic Control-Microbial Biotransformation of PhytochemicalsReviewInterventionsPaper
Irish Medical Journal·Jan 27Linagliptan-associated delirium in an older patientCase reportDeliriumPaper
Clinical Obesity·Jan 19Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative ReviewSystematic reviewGLP-1 receptor agonistsPaper